CC1C(C)=C(C(C2N=CNC=2)C)C=CC=1.[CH3:16][CH2:17][NH:18][C:19]([C@H:21]1[N:25]([C:26]([C@@H:28]([NH:36][C:37]([C@@H:39]([NH:44][C:45]([C@H:47]([NH:52][C:53]([C@@H:55]([NH:64][C:65]([C@@H:67]([NH:70][C:71]([C@@H:73]([NH:84][C:85]([C@@H:87]([NH:94][C:95]([C@H:97]2[NH:102][C:100](=[O:101])[CH2:99][CH2:98]2)=[O:96])[CH2:88][C:89]2[N:93]=[CH:92][NH:91][CH:90]=2)=[O:86])[CH2:74][C:75]2[C:79]3[CH:80]=[CH:81][CH:82]=[CH:83][C:78]=3[NH:77][CH:76]=2)=[O:72])[CH2:68][OH:69])=[O:66])[CH2:56][C:57]2[CH:58]=[CH:59][C:60]([OH:63])=[CH:61][CH:62]=2)=[O:54])[CH2:48][CH:49]([CH3:51])[CH3:50])=[O:46])[CH2:40][CH:41]([CH3:43])[CH3:42])=[O:38])[CH2:29][CH2:30][CH2:31][NH:32][C:33]([NH2:35])=[NH:34])=[O:27])[CH2:24][CH2:23][CH2:22]1)=[O:20].CC(O)=O>O>[CH3:16][CH2:17][NH:18][C:19]([C@H:21]1[N:25]([C:26]([C@@H:28]([NH:36][C:37]([C@@H:39]([NH:44][C:45]([C@H:47]([NH:52][C:53]([C@@H:55]([NH:64][C:65]([C@@H:67]([NH:70][C:71]([C@@H:73]([NH:84][C:85]([C@@H:87]([NH:94][C:95]([C@H:97]2[NH:102][C:100](=[O:101])[CH2:99][CH2:98]2)=[O:96])[CH2:88][C:89]2[N:93]=[CH:92][NH:91][CH:90]=2)=[O:86])[CH2:74][C:75]2[C:79]3[CH:80]=[CH:81][CH:82]=[CH:83][C:78]=3[NH:77][CH:76]=2)=[O:72])[CH2:68][OH:69])=[O:66])[CH2:56][C:57]2[CH:62]=[CH:61][C:60]([OH:63])=[CH:59][CH:58]=2)=[O:54])[CH2:48][CH:49]([CH3:51])[CH3:50])=[O:46])[CH2:40][CH:41]([CH3:43])[CH3:42])=[O:38])[CH2:29][CH2:30][CH2:31][NH:32][C:33]([NH2:35])=[NH:34])=[O:27])[CH2:24][CH2:23][CH2:22]1)=[O:20]Beagle dogs (10-15 Kg) were sedated with medetomidine (80 μg/kg) and an endoscope was inserted via the mouth, esophagus and stomach into the duodenum. The test solutions (10 ml), comprising leuprolide acetate (Mallinckrodt Inc, St. Louis, Mo.) with or without enhancer reconstituted in deionized water were administered intraduodenally via the endoscope. Following removal of the endoscope, sedation was reversed using atipamezole (400 μg/kg). The parenteral reference solutions comprising 1 mg Leuprolide reconstituted in 0.5 ml sterile water were administered intravenously and subcutaneously respectively.